Navigation Links
Takeda to Acquire Inviragen, Inc.
Date:5/7/2013

OSAKA, Japan and DEERFIELD, Ill. and FORT COLLINS, Colo., May 7, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and Inviragen, Inc. ("Inviragen") jointly announced today that Takeda, its wholly owned subsidiary Takeda America Holdings, Inc., and Inviragen, Inc. have entered into a definitive agreement for Takeda to acquire Inviragen for an upfront payment of US$35 million, and future payments of up to US$215 million linked to the progress of clinical development and achievement of key commercial milestones. Headquartered in Fort Collins, CO, with facilities in Madison, WI and Singapore, Inviragen is a privately-held biopharmaceutical company specializing in research and development of innovative vaccines for emerging infectious diseases, including dengue and hand, foot and mouth disease (HFMD).

"Takeda has taken another major step toward its goal of establishing a world-class global vaccine business by acquiring Inviragen and its advanced vaccine candidate against dengue, a serious mosquito-borne illness that threatens nearly half of the world's population," said Rajeev Venkayya, M.D., executive vice president and head of Takeda's Vaccine Business Division. "Today's announcement reinforces Takeda's commitment to develop innovative vaccines to fight some of the world's most important infectious diseases."

Inviragen has created innovative products using its expertise in viral vaccines. The company's lead candidate, DENVax, is a four-strain recombinant viral vaccine for the prevention of dengue infection. An administration schedule of two doses of DENVax over 90 days is currently being evaluated in Phase 2 clinical trials. In addition to DENVax, Inviragen's pipeline contains a vaccine candidate to protect against hand, foot and mouth disease (HFMD) caused by enterovirus 71 (EV71), which has compl
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda Responds to Verdict in Diabetes Drug Case
2. Takeda Launches New Subsidiary in Ecuador
3. Takeda lanza nueva subsidiaria en Ecuador
4. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
5. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
6. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
7. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
8. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
9. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
10. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
11. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Sept. 16, 2014 Research and Markets ... Market 2014-2018" report to their offering. ... of animals. Animal vaccines are generally prepared from weakened or ... their healthy state. Some of the animal vaccines are also ... protein subunits or toxic components. These components ...
(Date:9/16/2014)... 2014  Advanced Medical Isotope Corporation ("AMIC") ... engaged primarily in the development of brachytherapy ... therapeutic applications, today announced that a patent ... brachytherapy products.  AMIC,s rights for the newly ... Battelle, under which AMIC exclusively licensed technologies ...
(Date:9/16/2014)... TUCSON, Ariz. , Sept. 16, 2014 ... describe in a case report the first ... (TAH-t) in a 13- year-old boy with failing Fontan ... When he was 3 years old, the patient ... condition known as functional single ventricle. "The Fontan operation ...
Breaking Medicine Technology:Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 413-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 213-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 3
... breakthrough in mental health has been developed, a cooperative ... Foundation; a preventative care program called "Safe ,til Stable." ... time of need through our live 24-hour emergency response ... the trauma experienced by individuals impacted with bipolar disorder. ...
... A Chicago woman will be among the first in the country to, ... get rid of Gastrointestinal Esophageal Reflux Disease (GERD), ... transorally, through the mouth. ... the body, the doctor uses a device to, ...
Cached Medicine Technology:Break-through Preventative Care Program for People Living With Bipolar Disorder 2New Incision-Less Procedure for REFLUX - Experts Consider it to Be Gold Standard for REFLUX 2
(Date:9/16/2014)... Sept. 16, 2014 (HealthDay News) -- Modern forensic techniques ... injuries might have killed King Richard III, the last ... analysis of the king,s skeletal remains, using whole-body CT ... detailed account of the 11 injuries he suffered at ... Aug. 22, 1485. The modern forensics revealed that ...
(Date:9/16/2014)... Not all recovery plans are alike, and ... sure all their patients are receiving the treatment that ... the newly-introduced online therapy. Millennium Treatment Group recently launched ... opportunity to seek treatment from home. , With online ... care at a distance. They provide patients with all ...
(Date:9/16/2014)... 16, 2014 Duke’s Chowder House Lake ... Rebls and Gratafy for a fun evening of ... is firmly cemented. With the growth of companies in these sectors, ... people who work in tech and at startups to connect with ... are happy to host events for their peers to meet and ...
(Date:9/16/2014)... 14, 2014 A new clinical trial ... and drug-eluting balloons (DEB) in treating in-stent ... EES provided superior late angiographic results and ... were reported today at the 26th annual ... by the Cardiovascular Research Foundation (CRF), TCT ...
(Date:9/16/2014)... Programs and policies that promote health and ... dollars in savings for the US health system, according ... help spur these types of improvements, the National Quality ... from across the country to field test the NQF ... handbook designed to assist groups working together to improve ...
Breaking Medicine News(10 mins):Health News:Modern Forensics Provides Clues to Death of Richard III 2Health News:Millennium Treatment Group Now Offers Online Therapy 2Health News:Seattle Seafood Restaurant Duke’s Chowder House Partners with Rebls & Gratafy for Tech Networking Happy Hour Event. 2Health News:Seattle Seafood Restaurant Duke’s Chowder House Partners with Rebls & Gratafy for Tech Networking Happy Hour Event. 3Health News:Results of RIBS IV trial reported at TCT 2014 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 3
... the past two decades, medication errors have dramatically increased. DecisionHealth, ... potentially harmful medication errors. , ... Gaithersburg, MD (PRWEB) ... Health Ledger,s recent drug overdose, increased dramatically over the past two ...
... Ind., Aug. 14 Jay C stores are asking,customers ... purchased with,"sell by" dates of July 2 through August ... by Nebraska Beef. Customers should return the ground beef,to ... The recall involves 29 stores Jay C operates in ...
... the Treeman, and the American Doctor Racing to Cure Him on Sunday, ... ... SPRING, Md., Aug. 14 The bizarre growths,covering his body have made Indonesia,s ... Discovery,Health will go beyond the headlines and the tabloids to present the,dramatic true ...
... & enforceable union,election ground rules, ORANGE, Calif., Aug. ... United Healthcare Workers - West:, Caregivers who work ... open letter to the Sisters of St. Joseph of ... the unlawful threats and,intimidation of workers who support forming ...
... Aug. 13 As reported in publications and news,outlets ... "buck" teeth was replaced at the summer games opening ... the decision spawned,disbelief around the globe, sadly, the phenomenon ... of their teeth is nothing new., In a ...
... Corporation, a leading,international manufacturer, marketer, and supplier of ... its financial,results for the second quarter of 2008., ... quarter were $275.2 million, an,increase of 13.9% over ... quarter of,2007. Excluding the impact of favorable foreign ...
Cached Medicine News:Health News:Fatalities From Medication Errors at Home Up Dramatically - DecisionHealth Offers Solutions 2Health News:Fatalities From Medication Errors at Home Up Dramatically - DecisionHealth Offers Solutions 3Health News:Discovery Health Offers the Definitive Look at Indonesia's 'Treeman' in TREEMAN: SEARCH FOR THE CURE 2Health News:Discovery Health Offers the Definitive Look at Indonesia's 'Treeman' in TREEMAN: SEARCH FOR THE CURE 3Health News:As Charges Mount, Caregivers and Supporters Call on Sisters of St. Joseph of Orange to Help Stop Unlawful Intimidation of Workers 2Health News:Summer Games 'Swap' Raises Questions About Image, Oral Health 2Health News:Pregis Announces Second Quarter 2008 Financial Results 2Health News:Pregis Announces Second Quarter 2008 Financial Results 3Health News:Pregis Announces Second Quarter 2008 Financial Results 4Health News:Pregis Announces Second Quarter 2008 Financial Results 5Health News:Pregis Announces Second Quarter 2008 Financial Results 6Health News:Pregis Announces Second Quarter 2008 Financial Results 7Health News:Pregis Announces Second Quarter 2008 Financial Results 8Health News:Pregis Announces Second Quarter 2008 Financial Results 9Health News:Pregis Announces Second Quarter 2008 Financial Results 10Health News:Pregis Announces Second Quarter 2008 Financial Results 11Health News:Pregis Announces Second Quarter 2008 Financial Results 12
... Ruschelit® PVC. 2 eyes, oral. ... patient age. X-ray opaque line. Graduated. ... Designed to reduce kinking of the ... Ruschelit® PVC adapts to the anatomical ...
... Set® Tube with stylet inside. Sterile, ... uncuffed Rusch endotracheal tube with a ... use saving you time and storage ... for easy identification and has a ...
... Clear Plus™ Cuffed Endotracheal Tube w. Flexi -Slip™ ... Single use. A quality Rusch endotracheal tube with ... saving you time and storage space. The stylet ... withdrawal. It is designed with a soft distal ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Medicine Products: